The University of Chicago Header Logo

Hyperprogressive disease in patients with non-small cell lung cancer on immunotherapy.

Hyperprogressive disease in patients with non-small cell lung cancer on immunotherapy. J Thorac Dis. 2018 Feb; 10(2):1124-1128.

View in: PubMed